SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-20-000082
Filing Date
2020-06-03
Accepted
2020-06-03 06:08:55
Documents
1
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159117891482479.html 4  
1 FORM 4 wf-form4_159117891482479.xml 4 10606
  Complete submission text file 0001395064-20-000082.txt   12810
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 20938882
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 SHIRE WAY LEXINGTON MA 02421
Business Address 300 SHIRE WAY LEXINGTON MA 02421 (617) 588-8119
Shire Human Genetic Therapies, Inc. (Reporting) CIK: 0001745009 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 20938883